Equillium (EQ) Assets (2017 - 2026)
Equillium (EQ) posted quarterly Assets of $63.1 million for Q1 2026, up 277.09% year-over-year from $16.7 million in Q1 2025, and up 97.83% quarter-over-quarter from $31.9 million in Q4 2025.
Analysis
Equillium (EQ) Assets (2017 - 2026) Analysis & Trends
Equillium (EQ) has reported Assets for 10 consecutive years, with $63.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 277.09% year-over-year to $63.1 million; the TTM figure through Mar 2026 stood at $63.1 million (up 277.09% YoY), while the FY2025 annual figure was $31.9 million, up 24.54% from the prior year.
- Assets rose to $63.1 million in Q1 2026 per EQ's latest filing, from $31.9 million in the prior quarter.
- Across five years, Assets topped out at $71.8 million in Q1 2023 and bottomed at $12.4 million in Q2 2025.
- Historically, Assets has averaged $38.8 million across 5 years, with a median of $34.5 million in 2025.
- Annual changes were most pronounced in 2022 — Assets sank 78.43% — and 2026, when it soared 277.09%.
- Equillium's Assets stood at $23.0 million in 2022, then jumped by 119.23% to $50.5 million in 2023, then tumbled by 49.33% to $25.6 million in 2024, then grew by 24.54% to $31.9 million in 2025, then surged by 97.83% to $63.1 million in 2026.
- Business Quant data shows EQ's Assets at $63.1 million in Q1 2026, $31.9 million in Q4 2025, and $34.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - | 58.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.67 Mn |
| Mar 31, 2026 | 63.08 Mn |
| Dec 31, 2025 | 31.89 Mn |
| Sep 30, 2025 | 34.51 Mn |
| Jun 30, 2025 | 12.40 Mn |
| Mar 31, 2025 | 16.73 Mn |
| Dec 31, 2024 | 25.60 Mn |
| Sep 30, 2024 | 34.46 Mn |
| Jun 30, 2024 | 42.86 Mn |
| Mar 31, 2024 | 43.60 Mn |
| Dec 31, 2023 | 50.53 Mn |
| Sep 30, 2023 | 55.23 Mn |
| Jun 30, 2023 | 58.76 Mn |
| Mar 31, 2023 | 71.79 Mn |
| Dec 31, 2022 | 78.42 Mn |
| Sep 30, 2022 | 48.63 Mn |
| Jun 30, 2022 | 23.05 Mn |
| Mar 31, 2022 | 23.05 Mn |
| Dec 31, 2021 | 85.41 Mn |
| Sep 30, 2021 | 92.47 Mn |